Jason Wittes
Stock Analyst at Roth MKM
(3.57)
# 898
Out of 4,736 analysts
55
Total ratings
55.32%
Success rate
5.15%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $93.32 | +23.23% | 4 | Dec 17, 2024 | |
| MGRM Monogram Technologies | Initiates: Buy | $4 | $2.85 | +40.35% | 1 | Dec 9, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Buy | $11 | $4.90 | +124.49% | 1 | Nov 11, 2024 | |
| OFIX Orthofix Medical | Reiterates: Buy | $20 → $22 | $18.38 | +19.70% | 4 | Nov 8, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $50 | $3.05 | +1,539.34% | 1 | Sep 6, 2024 | |
| IRMD IRADIMED CORPORATION | Maintains: Buy | $65 → $60 | $59.32 | +1.15% | 2 | Aug 2, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $7.01 | +413.92% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $3.68 | +198.91% | 1 | Jun 28, 2024 | |
| CRDL Cardiol Therapeutics | Initiates: Buy | $10 | $1.32 | +657.58% | 1 | Jun 26, 2024 | |
| LMAT LeMaitre Vascular | Reinstates: Buy | $100 | $98.00 | +2.04% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.81 | +452.49% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $348 → $405 | $390.49 | +3.72% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.19 | +128.31% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.28 | +294.74% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $47.02 | +59.51% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $11.38 | +93.32% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $109.72 | +9.37% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $173.16 | +18.97% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $185.65 | -21.90% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.05 | +35.75% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $26.83 | +645.57% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $29.14 | -10.78% | 1 | Feb 22, 2017 |
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $93.32
Upside: +23.23%
Monogram Technologies
Dec 9, 2024
Initiates: Buy
Price Target: $4
Current: $2.85
Upside: +40.35%
TriSalus Life Sciences
Nov 11, 2024
Initiates: Buy
Price Target: $11
Current: $4.90
Upside: +124.49%
Orthofix Medical
Nov 8, 2024
Reiterates: Buy
Price Target: $20 → $22
Current: $18.38
Upside: +19.70%
Allurion Technologies
Sep 6, 2024
Initiates: Buy
Price Target: $50
Current: $3.05
Upside: +1,539.34%
IRADIMED CORPORATION
Aug 2, 2024
Maintains: Buy
Price Target: $65 → $60
Current: $59.32
Upside: +1.15%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $7.01
Upside: +413.92%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $3.68
Upside: +198.91%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.32
Upside: +657.58%
LeMaitre Vascular
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $98.00
Upside: +2.04%
May 16, 2024
Reiterates: Buy
Price Target: $10
Current: $1.81
Upside: +452.49%
May 1, 2024
Maintains: Buy
Price Target: $348 → $405
Current: $390.49
Upside: +3.72%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.19
Upside: +128.31%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $2.28
Upside: +294.74%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $47.02
Upside: +59.51%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $11.38
Upside: +93.32%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $109.72
Upside: +9.37%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $173.16
Upside: +18.97%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $185.65
Upside: -21.90%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $11.05
Upside: +35.75%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $26.83
Upside: +645.57%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $29.14
Upside: -10.78%